535 related articles for article (PubMed ID: 9227787)
21. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-sestamibi scintimammography to detect breast cancer in patients with paraffinomas or siliconomas after breast augmentation.
Peng NJ; Chang HT; Tsay DG; Liu RS
Cancer Biother Radiopharm; 2003 Aug; 18(4):573-80. PubMed ID: 14503952
[TBL] [Abstract][Full Text] [Related]
23. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
24. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
Scopinaro F; Ierardi M; Porfiri LM; Tiberio NS; De Vincentis G; Mezi S; Cannas P; Gigliotti T; Marzetti L
Anticancer Res; 1997; 17(3B):1635-8. PubMed ID: 9179209
[TBL] [Abstract][Full Text] [Related]
26. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
[TBL] [Abstract][Full Text] [Related]
27. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
28. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
29. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer.
Brem RF; Rapelyea JA; Zisman G; Mohtashemi K; Raub J; Teal CB; Majewski S; Welch BL
Radiology; 2005 Oct; 237(1):274-80. PubMed ID: 16126919
[TBL] [Abstract][Full Text] [Related]
30. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
Myslivecek M; Koranda P; Kamínek M; Husák V; Hartlová M; Dusková M; Cwiertka K
Nucl Med Rev Cent East Eur; 2004; 7(2):151-5. PubMed ID: 15968602
[TBL] [Abstract][Full Text] [Related]
31. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
32. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
33. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
[TBL] [Abstract][Full Text] [Related]
35. Mammotomography with pinhole incomplete circular orbit SPECT.
Tornai MP; Bowsher JE; Jaszczak RJ; Pieper BC; Greer KL; Hardenbergh PH; Coleman RE
J Nucl Med; 2003 Apr; 44(4):583-93. PubMed ID: 12679403
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma.
Howarth D; Sillar R; Clark D; Lan L
Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
[TBL] [Abstract][Full Text] [Related]
38. Detection of axillary lymph node metastases in breast cancer with Tc-99m tetrofosmin scintigraphy.
Schillaci O; Scopinaro F; Spanu A; Donnetti M; Danieli R; Di Luzio E; Madeddu G; David V
Int J Oncol; 2002 Mar; 20(3):483-7. PubMed ID: 11836558
[TBL] [Abstract][Full Text] [Related]
39. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses.
Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS
Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
